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Abstract.  A demyelinating disease induced in 
C57B1/6N  mice by intracranial injection of a corona- 
virus (murine hepatitis virus strain A59) is followed 
by functional recovery and efficient CNS myelin re- 
pair.  To study the biological properties of the cells in- 
volved in this repair process, glial ceils were isolated 
and cultured from spinal cords of these young adult 
mice during demyelination and remyelination. Using 
three-color immunofluorescence combined with 
[3H]thymidine autoradiography, we have analyzed the 
antigenic phenotype and mitotic potential of individual 
glial cells. We identified oligodendrocytes with an an- 
tibody to galactocerebroside, astrocytes with an anti- 
body to glial fibrillary acidic protein, and 
oligodendrocyte-type 2 astrocyte (O-2A) progenitor 
cells with the 04 antibody. Cultures from demyeli- 
nated tissue differed in several ways from those of age- 
matched controls: first, the total number of O-2A lin- 
cage cells was strikingly increased; second, the O-2A 
population consisted of a higher proportion of 04- 
positive astrocytes and cells of mixed oligodendrocyte- 
astrocyte phenotype; and third, all the cell types 
within the O-2A lineage showed enhanced prolifera- 
tion. This proliferation was not further enhanced by 
adding PDGF, basic fibroblast growth factor (bFGF), 
or insulin-like growth factor I (IGF-I) to the defined 
medium. However, bFGF and IGF-I seemed to 
influence the fate of O-2A lineage cells in cultures of 
demyelinated tissue. Basic FGF decreased the percent- 
age of cells expressing galactocerebroside. In contrast, 
IGF-I increased the relative proportion of oligodendro- 
cytes. Thus, O-2A lineage cells from adult mice display 
greater phenotypic plasticity and enhanced mitotic 
potential in response to an episode of demyelination. 
These properties may be linked to the efficient remye- 
lination achieved in this demyelinating disease. 
I 
~ demyelinating diseases, damage to myelin sheaths dis- 
rupts conduction of electrical impulses  along  axonal 
processes of neurons. Typically, damaged myelin is not 
efficiently repaired in the human CNS (Perier and Gregoire, 
1965; Prineas et al., 1984). Thus patients with CNS demy- 
elinating diseases, such as multiple sclerosis, frequently ex- 
perience prolonged neurological  dysfunction.  In contrast, 
efficient remyelination  and functional recovery is achieved in 
rodents in certain experimental models of CNS demyelina- 
tion (reviewed in Ludwin, 1981). One such model is pro- 
duced by infecting C57B1/6N mice with a coronavirus (mu- 
rine hepatitis virus strain A59; MHV-A59), which leads to 
the  development  of multiple  CNS  demyelinating  lesions 
(Lavi et al.,  1984; Jordan et al.,  1989). This coronavirus 
replicates in glial cells during an early phase of the disease 
and is subsequently  cleared from the CNS (Jordan  et al., 
1989). Infected  mice exhibit clinical signs of CNS demyelin- 
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ation within  the first  week post infection  (wpi)?  By 3-5 
wpi, focal areas of demyelination are present throughout the 
CNS, with prominent lesions in the spinal cord. In the fol- 
lowing  weeks,  remyelination  is  paralleled by  functional 
recovery. Using this model, we can analyze the processes in- 
volved in regeneration of the cells that form CNS myelin. 
Myelination in the developing CNS requires the coordi- 
nated interaction of several types of glial cells (reviewed in 
Raine, 1984; Wood and Bunge, 1984; Raft,  1989). In vitro 
studies of optic nerve from newborn rat have characterized 
a bipotential progenitbr cell that can give rise to oligoden- 
drocytes or to type 2 astrocytes, 'and is therefore called an 
oligodendrocyte-type 2  astrocyte  (O-2A)  progenitor cell. 
Type 2 astrocytes express antigens that are also present on 
the surface of O-2A progenitor cells.  The localization  and 
function of  type 2 astrocytes in vivo is not clear at the present 
time. Another type of astrocyte, called the type 1 astrocyte; 
appears  before type 2  astrocytes and arises  from a  glial 
1. Abbreviations used in thispaper: div, days in vitro; GC, galactoeerebro- 
side; GFAP, glial fibrillary acidic protein; MHV-A59, rnurine hepatitis virus 
strain A59; O-2A, oligodendrocyte-type  2 astrocyte; wpi, weeks post infection. 
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1984).  Type 1 astrocytes secrete growth factors that affect 
the proliferation,  migration,  and/or differentiation of O-2A 
progenitors  (reviewed  in  Raft,  1989;  Dubois-Dalcq  and 
Armstrong,  1990). Upon maturation,  oligodendrocytes elab- 
orate extensive processes which wrap around CNS axons to 
form myelin (reviewed in Paine, 1984). Perinodal astrocytes, 
possibly type 2 astrocytes, extend processes to nodes of Ran- 
vier,  which are electrically excitable regions of axons be- 
tween adjacent myelin sheaths (ffrench-Constant  and Raft, 
1986b; ffrench-Constant et al., 1986). Both oligodendrocytes 
and perinodal astrocytes seem to play a role in efficient salta- 
tory conduction of nerve impulses; myelin acts as an electri- 
cal insulator while perinodal astrocytic processes may serve 
various functions associated with impulse propagation at nodes 
(discussed in Ritchie,  1984; Black and Waxman,  1988). 
In normal  adult CNS oligodendrocytes proliferate mini- 
mally (McCarthy and Leblond,  1988). Attempts to induce 
in vitro mitosis of oligodendrocytes with exogenous growth 
factors have not been successful (Yong et al.,  1988). How- 
ever, oligodendrocytes isolated from adult CNS do prolifer- 
ate when cocultured with neurons (Wood and Bunge, 1986). 
In addition, O-2A progenitor cells isolated from adult rat op- 
tic nerve are capable of proliferating in vitro in the absence 
of neurons and maintain the ability to differentiate (ffrench- 
Constant and Raft, 1986a; Wolswijk and Noble, 1989). These 
studies provide evidence that oligodendrocytes and/or O-2A 
progenitor cells may contribute to the regeneration of O-2A 
lineage cells in the adult CNS. 
After widespread CNS demyelination, surviving oligoden- 
drocytes at the periphery of lesions do not seem to be able 
to elaborate myelinating processes and/or relocate to achieve 
efficient remyelination.  Proliferation of oligodendrocytes, or 
oligodendrocTte  precursor  cells,  during  demyelination  ap- 
pears to be necessary to facilitate remyelination. Electron mi- 
croscopic autoradiographic  analyses of demyelinating tissue 
have reported mitosis of oligodendrocytes at several stages of 
maturation  (Herndon et al.,  1977;  Ludwin,  1979; Aranella 
and Herndon,  1984; Ludwin and Bakker,  1988). A recent in 
vivo analysis combining immunolabeling with autoradiogra- 
phy has shown that O-2A progenitor cells and astrocytes that 
express 04 antigens proliferate early in the course of demyeli- 
nation induced by coronavirus infection and that some cells 
generated  during  demyelination  later  became oligodendro- 
cytes (Godfraind et al.,  1989). In the present study, we have 
developed an in vitro system to further characterize the cells 
involved in the remyelination process. We have used three- 
color immunofluorescence combined with autoradiography to 
identify specific glial cell types. In such a system we can ana- 
lyze  the proliferative  capacity, phenotypic plasticity,  and 
differentiation  potential  of the various types of glial  cells 
which may play  a key role  in CNS remyelination. 
Materials and Methods 
Coronavirus Infection 
Female C57B1/6N  mice, without prior exposure  to MHV-A59, were ob- 
tained from the Frederick Cancer Research Facility  (Frederick, MD). At 
28 d  of age each mouse was  injected intracranially with 1,000 plaque- 
forming units of coronavirus (MI-IV-A59), which had been propagated  in 
the 17 CI 1 line of spontaneously transformed BALB/c 3T3 cells (Sturman 
et al., 1980). This age and inoculation dosage op  "ttmized the proportion of 
mice developing  demyelinating  lesions  ('069  %) relative  to  the  incidence  of 
acute  mortality  (,o11%). 
Glial Cell Isolation 
At 1, 3, 4, 5, or 8 wpi, mice were anesthetized with methoxyflurane  and 
then decapitated.  For each glial cell isolation,  spinal cords remov&t from 
three infected mice exhibiting neurological  dysfunction (Woyciechowska et 
al.,  1984) were combined and spinal cord tissue from three age-matched 
control mice was prepared simultaneously.  Spinal cords were minced and 
then dissociated  according  to a  procedure modified  from Miller et al. 
(1985). The tissue was incubated at 37°C with enzymes (twice for 20 rain 
in 0.125% trypsin with 0.02% collagenase  in MEM-Hepes followed by one 
15-min incubation in 0.05 % trypsin with 0.53 M EDTA), bathed in a solu- 
tion that inhibited trypsin and digested free DNA (0.25%  soybean trypsin 
inhibitor, 0.002% DNase I, 0.166% BSA, and 5% FBS in DME) and pas- 
saged through pipettes (5 ml, 10 times; 1 ml, 10 times; Pasteur pipette 10 
times). Floating cells were transferred to a 50-ml tube which was then filled 
with isolation medium (1 mM Hepes,  50 U/ml penicillin, 50 #g/ml strep~ 
tomycin, and 25/zg/ml gentamycin in HBSS without calcium or magnesium, 
pH 7.4) and spun for 10 min at 1,500 rpm in a centrifuge (GLC-2B; Sorvall 
Die.,  Newton, CT). The supernatant was removed and pelleted cells were 
resuspended in 10 ml of isolation medium. 
Glial cells were separated from myelin and red blood cells using a 30% 
Percoll gradient (Hirayama  et al.,  1983; Kim et al.,  1985). The gradient 
was centrifuged in an ultracentrifuge (Beckman Instruments,  Palo Alto, CA) 
equipped  with a JA20 fixed-angle rotor spun at 14,000 rpm for 45 min at 
4°C. The glial cell layer, the region below the myelin cap and above the red 
blood cells, was transferred to a 50-ml tube that was then filled with isola- 
tion medium and spun for 10 minutes at 1,500 rpm in a centrifuge (GLC-2B; 
Sorvall  Div.).  The supernatant was removed  and the pelleted cells were 
resuspended (800 pl/spinal cord) in 10% FBS in DME with 584 mg/liter 
L-glutamine, 4.5 g/liter v-glucose, 25 #g/ml gentamycin, and 1 mM sodium 
pyruvate. In all cases, 200 ~tl of cell suspension was plated per 35-mm plas- 
tic dish (coated with extracellular matrix; Accurate Chemical & Scientific 
Corp., Westbury, NY). After incubating for 1 h at 37°C to enhance attach- 
ment, the cultures were fed with 2 ml of 10% FBS-DME solution.  At 1 and 
3 d in vitro (die) cultures were fed with 0.5 % FBS in defined medium (DME 
with 584 mg/liter L-glutamine,  4.5 g/liter v-glucose,  5/~g/ml insulin, 50 
/~g/ml transferrin, 30 nM selenium, 30 nM triiodothyronine, 25 #g/ml gen- 
tamycin, and 1 mM sodium pyruvate;  modified from Eccleston and Silber- 
berg, 1984). The cultures were grown in this low serum defined medium 
to enhance the growth of oligodendrocytes  relative to fibroblasts.  After l, 
3, or 6 die, cultures were fixed with 2% paraformaldehyde  in MEM-Hepes 
for 15 min. 
pH]Thymidine Labeling 
In some experiments a  terminal pulse of [methyl-3H]thymi~me  (67  Ci/ 
mmol; New England Nuclear,  Boston, MA) was administered. For in vivo 
labeling, mice were injected intraperitoneally  with [3I-l]thymidine  (10 #Ci/g 
body weight) 2 h before death (see Fig.  1 A). For in vitro labeling,  [3H]thy- 
midine (0.05 #Ci/ml culture media) was added to cultures 20 h before fixa- 
tion (see Fig.  1 B). 
Growth Factors 
The growth factors tested were bovine bFGF (10 ng/mi; R & D Systems, 
Minneapolis, MN), human PDGF (10 ng/mi; A and B chain heterodimer 
from R & D Systems), and human insulin-like growth factor I (IGF-I; 100 
ng/mi; Amgen Biologicals,  Thousand Oaks, CA). Each growth factor was 
added individually to a culture dish at 1 div with 0.5%  FBS in defined 
medium (see above).  Cultures were subsequently given a 20-h terminal 
pulse of [3I-I]thymidine and fixed at 3 die (see Fig.  1 C). 
Immunocytochemistry 
O-2A lineage cells were identified based upon three-color immnnofluores- 
cence  that  enabled simultaneous visualization of reactivity  with  anti- 
galactocerebroside (GC), anti-glial fibrlllary acidic protein (GFAP),  and 
the 04 antibody. Anti-GC is a mouse monoclonal IgG3, kindly provided by 
B. Ranscht (La Jolia Cancer Research Foundation, La Jolla, CA),  which 
recognizes  GC and an earlier antigen emerging on the cell surface shortly 
after the appearance of 04 immunostaining (Ranscht et al.,  1982; Bansal 
et al., 1989). The rabbit  polyclonal anti-GFAP, kindly provided by R. Pruss 
(Merrill Dow Pharmaceuticals,  Cincinnati, OH), immunostains GFAP but 
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Figure 1. Experimental design followed for the in vivo 
and in vitro [3H]thymidine labeling studies of O-2A 
lineage cells and their response to growth factors. 
does not react with other intermediate filament proteins (Pruss et al., 1979). 
04 is a mouse monoclonal IgM, kindly provided by 1. Sommer (Southern 
General Hospital, Glasgow, Scotland), (Sommer and Schachner, 1981) which 
recognizes sulfatide, seminolipid, and an unidentified  antigen (Bansal et al., 
1989). 
04 and anti-GC were supernatants from hybridoma cultures containing 
10% FBS in DME. The supernntants were mixed together and diluted 1:4 
and 1:2, respectively,  in a MEM-Hepes buffer solution (0.1% gelatin, 1% 
BSA, and 0.05%  sodium azide in MEM-Hepos) and applied to the fixed 
cells for 1-2 h. 04 was visualized with rhodamine conjugated  goat anti- 
mouse IgM (25 t~g/mi; Jackson Immunoresearch Laboratories, West Grove, 
PA). Anti-GC was visualized with fluorescein conjugated goat anti-mouse 
IgG3 (16.6 tzg/ml; Fischer Biotech, Orangeburg,  NY). These secondary an- 
tibodies were also mixed together in MEM-Hepes buffer solution and ap- 
plied for 1-2 h. After washing, the cultures were fixed with 5 % glacial acetic 
acid in ethanol for 10 min at -20"C to expose  internal cellular antigens. 
This was followed by three washes  in 10% FBS MEM-Hepes and three 
washes in 0.5M Tris buffer. Polyclonal rabbit anti-GFAP was diluted 1:2,000 
in a Tris buffer solution (0.1% gelatin, 1% BSA, and 0.05% sodium azide 
in 0.5M Tris buffer) for binding overnight at 4"C. Anti-GFAP was visualized 
with biotinylated donkey anti-rabbit IgG (10/~g/ml in the Tris buffer solu- 
tion, 1-2 h; Amersham Chemical Co., Arlington Heights,  IL) followed by 
streptavidin conjugated  7-amino-4-methyl-coumarin-3-acetic  acid (25/zg/ 
ml in the Tris buffer solution, 1-2 h; Molecular Probes,  Inc., Eugene, OR; 
Khallhn etal., 1986). Atter a final 5-rain fixation in 4% paraformaldeh)de the 
cultures were either coverslipped,  with a solution of 20 % 0.02 M Tris buffer 
(pH 8.2) and 80% glycerol,  or processed for autoradiography (see below). 
Immunostained cells were examined by epifluorescence  with a  Zeiss 
Photoscopo I11 equipped with three filter sets to simultaneously view rhoda- 
mine, fluorescein,  and coumarin fluorescence.  The absence of cross-reac- 
tion in the three-color immunofluorescence  protocol was tested by omitting, 
in turn, each one of the three primary antibodies while all other steps re- 
mained unchanged. Omission of each primary completely abolished bind- 
ing of the corresponding secondary but did not affect signals in the other 
two channels. 
In some cultures,  the presence of mixed oligodendrocyte-astrocyte phe- 
notype cells was confirmed with a second set of prirnary antibodies. These 
cultures were immunostained with 04, as described above, in combination 
with a rat mAb to GFAP (Lee et al., 1984) visualized with fluorescein and 
a rabbit polyclonal antiserum to GC, which was produced in our laboratory 
(according to the procedure described by Benjamins et al.,  1987),  and 
visualized with coumarin. 
Histological Sections 
A segment of each spinal cord was excised with a sterile razor blade before 
glial cell isolation.  Segments  were fixed by overnight immersion in 1% 
glutaraldehyde  and 2% paraformaldehyde  in 0.1 M phosphate buffer. The 
tissue was then washed for 1 d in buffer, postfixed with 2 % osmium tetmxide 
for 2 h, dehydrated  in graded alcohols, cleared with propylene oxide, and 
embedded in Epon resin. Transverse sections (1 ~m) were stained with tolu- 
idine blue. 
Autoradiography 
Cultured cells, labeled either in vivo or in vitro with [3H]thymidine, were 
immunostained and post-fixed as described above. The specimens were then 
dehydrated  in graded alcohols (50%, 75%, 95%; 30 seconds in each), air 
dried, coated with Kodak NTB2  nuclear track emulsion (diluted  1:2), ex- 
posed at 4°C for 5 d, developed at 16°C in Kodak D19, and fixed with Kodak 
fixer. After several washes, cultures were coverslipped as described above. 
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Figure 2. Glial cells isolated from spinal cords of diseased (i) and 
control (,) mice were cultured for 1 d and then O-2A lineage cells 
were identified by triple-label immunocytochemistry (as described 
in Results). The total number of O-2A lineage cells (oligodendro- 
cytes, O-2A progenitors, type 2  astrocytes, and mixed phenotype 
cells) in each 35-mm dish was counted. The number of O-2A lin- 
eage cells cultured from demyelinated tissue (3-5 wpi,  see Fig. 3 
C) is significantly greater than the number from control tissue (3 
wpi, p  =  0.015; 4  wpi, p  =  0.019; 5 wpi, p  =  0.069; paired two- 
tailed t test). For each glial cell isolation, the pellet from 3 spinal 
cords was plated onto 12 dishes. Each value represents the average 
of three to seven dishes combined from up to four series of animals. 
Error bars =  SEM. In all 5,988 O-2A lineage cells were counted. 
Armstrong et al. In Vitro Studies of Neuroglia during Demyelination  1185 Figure 3. A small segment of fresh tissue was excised from each spinal cord and processed for histological examination while the rest 
of the spinal cord was dissociated for in vitro studies. The progression of demyelination and remyelination  was followed in 1/~m  epoxy- 
embedded sections stained with toluidine blue. (A) In control tissue, intact myelinated axons are tightly packed within the white matter. 
(B) At 1 wpi, demyelination is not yet detected, although occasionally discrete lesions are present (not shown). (C) At 5 wpi, extensive 
myelin loss is accompanied by vacuolation and phagocytosis. (D) By 8 wpi, abnormally thin myelin sheaths indicate that remyelination 
is proceeding. Bar, 20/~m. 
Results 
Glial Cell 7)pes Isolated from Control and  from 
Infected Spinal Cord Tissue 
The glial cell population was characterized using three-color 
immunofluorescence  which enabled simultaneous visualiza- 
tion of three antigens, each labeled by one of three differ- 
ent fluorochromes (rhodamine, fluorescein, or coumarin). 
Oligodendrocytes were identified by expression of cell sur- 
face antigens recognized by anti-GC (Raft et al., 1978), Cells 
containing intracellular filaments immunostained with anti- 
GFAP were classified as astrocytes (Biguami et al.,  1972; 
Rafter al., 1979).  Type 2 astrocytes were distinguished from 
type 1 astrocytes by the expression of cell surface antigens 
recognized  by  the  04  antibody  (Trotter  and  Schachner, 
1989).  O-2A  progenitors  derived  from  adult  CNS  were 
identified as cells binding 04 in the absence of GC or GFAP 
immunolabeling (Wolswijk and Noble, 1989). Thus, any par- 
ticular cell could be identified as an oligodendrocyte (04+ 
GC+ GFAP-), a type 2 astrocyt¢ (04+ GFAP+ GC-), an 
O-2A progenitor (04+  GC-  GFAP-), a mixed oligoden- 
drocyte-astrocyte phenotype cell (04+  GC+  GFAP+), or 
a type 1 astrocyte (GFAP+ 04-  GC-). (In this paper, the 
term "type 2 astrocyte" will be used to denote only the 04+ 
GFAP+ GC- antigenic phenotype and is not intended to in- 
dicate a specific localization or function in vivo.) 
Glial cells were isolated and cultured in parallel from spi- 
nal cords of infected and age-matched control mice at several 
intervals after viral inoculation. These cultures contained 
various types of glial cells,  of which O-2A  lineage cells 
(oligodendrocytes, O-2A progenitors, type 2 astrocytes, and 
mixed phenotype cells) represented a small proportion of the 
total. The number of O-2A lineage cells was counted after 
1 d in culture (Fig. 2). This number was similar for control 
and experimental tissue at 1 wpi (Fig. 2) when demyelination 
was not yet detected (see Fig. 3, A and B). As demyelination 
and vacuolation progressed (3-5 wpi, see Fig. 3 C), O-2A 
lineage cells were much more abundant in cultures of the 
demyelinated tissue (Fig. 2).  With the onset of remyelina- 
tion (6-8 wpi, see Fig. 3 D), the number of O-2A lineage 
cells derived from lesioned tissue declined (Fig. 2). It is pos- 
sible that CNS inflammation and vacuolation may have fa- 
cilitated dissociation of the demyelinated tissue and thereby 
improved the yield of growing c¢11s. Yet the cultures from 
control versus demyelinated CNS differed not only in cell 
The Journal of Cell Biology, Volume  111, 1990  1186 Figure 4. At 1 div, type 1 astrocytes stained with anti-GFAP  antibodies (A) (but not by 04 and GC antibodies, not shown) form the dense 
clusters of ceils seen by phase microscopy (C). After 6 d in culture GFAP+ cells have spread out from the clusters (B) and proliferated, 
as assayed by the high proportion of nuclei which have incorporated [3H]thymidine  during the 3-d terminal pulse (D; same field as shown 
in B).  [3H]Thymidine-labeled  GFAP+ cells were also evident at 3 div after a 20-h pulse (not shown). Bar, 50 #m. 
number but also in antigenic phenotypes and mitotic poten- 
tial of the O-2A lineage cells. 
The other cell types in our cultures were type 1 astrocytes, 
fibroblasts, and microglia. Flat calls expressing GFAP but 
not 04 antigens were identified as type 1 astrocytes. Type 1 
astrocytes seemed to be more prevalent in cultures of le- 
sioned tissue.  However,  at  1 div  such cells were usually 
found in dense clusters that prohibited accurate quantitation 
of the initial type 1,astrocyte population (Fig. 4, A and C). 
By 3 and 6div, type 1 astrocytes grew out from these clusters 
and proliferated, as assayed by [3H]thymidine incorporation 
(Fig. 4, B and D). Flat cells presumed to be fibroblasts, due 
to the absence of 04, GC, or GFAP immunostaining, were 
present and p~liferated in all cultures examined (not shown). 
Microglia and/or macrophages were identified by their ame- 
boid appearance, the presence of phagocytic debris within 
the cells, and the absence of 04 immunostaining (Giulian, 
1987; Rieske et al., 1989).  Microglial ceils are the resident 
macrophages of the CNS and markers for distinguishing mi- 
croglia from blood-born macrophages, which can infiltrate 
the CNS,  are not presently available.  For simplicity, cells 
with the phenotype of microglia and/or macrophages will be 
referred to as microglia throughout this paper. These cells 
were rare in cultures of control tissue. In contrast, the num- 
ber of  microglia cultured from diseased tissue increased dra- 
matically during the period of demyelination (3-5 wpi). 
We identified Schwann cells with an antibody to the recep- 
tor for nerve growth factor (Chandler et al.,  1984) that la- 
beled Schwann cells cultured from rat sciatic nerve, which 
have been  shown to express this receptor (Yasuda  et al., 
1987; DiStefano and Johnson,  1988).  These cells were not 
detected in cultures of control or infected spinal cords (1 and 
4 wpi). Similarly, Schwarm cells were rarely observed in the 
remyelinating lesions (Fig. 3). 
In Vitro Phenotypes of O-2A Lineage Cells 
We then examined the relative abundances of the different 
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Figure  5.  Relative abundance  of specific phenotypes within the 
O-2A lineage population in cultures derived from demyelinated tis- 
sue (5 wpi) and those from age-matched  controls. Using triple-label 
immunocytochemistry, individual cells were identified as O-2A 
adult progenitors (O4), oligodendrocytes (04/GC),  type 2 astro- 
cytes (04/GFAP), or mixed phenotype cells (04/GC/GFAP) based 
upon which of the three glial cell markers were expressed. Cells 
of each phenotype were counted and the percentage of each within 
the total O-2A lineage population was calculated. Cultures of de- 
myelinated  tissue contained a higher proportion of  type 2 astrocytes 
and mixed phenotype cells than did control cultures. Each value 
represents the average of five dishes combined from three separate 
series of  anirnals. Error bars = SEM. A total of  3,913 O-2A lineage 
cells were counted. 
phenotypes within the O-2A lineage in cultures from control 
and demyelinated spinal cords (Fig. 5). In control cultures, 
the O-2A lineage population consisted primarily of oligo- 
dendrocytes (GC+  04+  GFAP-) (Figs.  5  and 6).  O-2A 
progenitor cells (04+  GC- GFAP-) were found at both 1 
and 3 div in these control cultures (Figs. 5 and 7). The rela- 
tive proportion of  type 2 astrocytes (04+ GFAP+ GC-) in- 
creased between 1 and 3 div, even though the cultures were 
maintained in defined medium with only 0.5 % FBS (Figs. 
5 and 7). Interestingly,  in cultures of neonatal rat optic nerve, 
10% FBS is required to induce development of a substantial 
number of type 2 astrocyteg (Raft et al.,  1983). 
In  cultures  of demyel~ated spinal  cord  tissue  (5  wpi), 
oligodendrocytes were the predominant cell type after 1 div 
(Fig. 5). However, a larger percentage of  the O-2A population 
was composed of type 2 astroeytes in these cultures as com- 
pared with cultures of control tissue. By 3 div, type 2 astro- 
cytes became even more prevalent than oligodendrocytes. At 
each time point, O-2A progenitor cells represented ,,020% of 
the O-2A lineage population. A remarkable feature in cul- 
tures from demyelinated tissue was the presence of mixed 
oligodendrocyte-astrocyte  phenotype cells, which were rarely 
seen in control cultures (Fig. 5). These cells expressed GC 
on their surface and contained intracellular filaments immuno- 
stained with GFAP (Fig.  8).  Such mixed phenotype cells 
(04+ GC+ GFAP+) were found consistently using two dif- 
ferent antibodies to GC in combination with two different  an- 
tibodies to GFAP (see Materials and Methods). 
Certain growth factors have been shown to have an effect 
on the fate of O-2A lineage cells: IGF-I promotes oligoden- 
drocyte development (McMorris et al., 1986), whereas bFGF 
inhibits myelin  gene expression (McKirmon and Dubois-Dalcq, 
1990). Therefore, we examined whether treatment with such 
growth factors from 1-3  div would influence the antigenic 
phenotypes expressed by O-2A lineage cells isolated during 
the course of demyelination and remyelination (Fig. 9).  In 
cultures of demyelinating/remyelinating tissue exogenous IGF-I 
increased the proportion of oligodendrocytes relative to type 
2 astrocytes, whereas bFGF decreased the relative number 
of oligodendrocytes. PDGF did not markedly alter the ratio 
of type 2 astrocytes to oligodendrocytes, in agreement with 
the observation that PDGF allows timely differentiation of 
oligodendroeytes and type 2 astroeytes in cultures of devel- 
oping CNS tissue (Noble et al.,  1988;  Raft et al.,  1988). 
In Vivo  and In Vitro Proliferation of  O-2A 
Lineage Cells 
In a previous in vivo study of this demyelinating disease, 
O-2A lineage cells which had incorporated [3I-l]thymidine 
during a 2-h terminal pulse were detected in 1-1zm  frozen sec- 
Figure 6.  An example of an oligodendrocyte  isolated  from normal adult (8-wk-old) mouse spinal cord which was grown in culture for 
3 d, fixed, and processed for three-color immunofluorescence.  (A) Phase contrast showing the thin, branched processes which are character- 
istic of an oligodendrocyte.  (8) This cell is labeled with galactocerebroside  antibody, which is visualized with fluorescein.  This cell also 
bound 04 but did not express  GFAP (not shown). Bar,  50 ttm. 
The Journal of Cell Biology, Volume 111, 1990  1188 Figure 7. A type 2 astroeyte (04+ GFAP+ GC-) and an O-2A progenitor (04+ GFAP- GC-) from normal adult (8-wk-old) mouse 
spinal cord which were grown in culture for 3 d, fixed, and processed for three-color immunofluorescenee.  Phase contrast reveals two 
process-bearing cells (A). The type 2 astroeyte in the bottom left quadrant (A) has intracellniar filaments stained with GFAP antiserum 
(B; coumarin optics) and also expresses surface antigens recognized by the 04 antibody (D; rhodamine optics) but not the GC antibody 
(C; fluorescein optics). The adult progenitor cell in the upper right quadrant (A) expresses 04 antigens (D) but not GFAP (B) or GC (C). 
Bar, 50 ~m. 
tions (Godfraind et al., 1989). To further explore the mitotic 
potential of  O-2A lineage cells from adult CNS, we prepared 
cultures from spinal cords of normal and infected mice after 
in vivo labeling with [3H]thymidine during a 2-h terminal 
pulse (Table I). Cells undergoing active DNA synthesis were 
identified after  1  div  by  [3I-I]thymidine autoradiography 
combined with triple-label immunocytochemistry, as out- 
lined in Fig.  1 A.  The  proportion of O-2A  lineage cells 
(oligodendrocytes, O-2A progenitors, and type 2 astrocytes) 
which were thymidine-labeled was extremely low in control 
cultures prepared from normal mice at 5 wk of age (0.52%) 
and at 8 wk of age (0 %). In contrast, the proportion of O-2A 
lineage cells (oligodendrocytes, O-2A progenitors, type 2 
astrocytes, and mixed phenotype cells) that were pH]thy- 
midine-labeled in cultures derived from infected tissue was 
markedly higher both in the early phase of the disease (4.96% 
at 1 wpi; 5 wk of age) and at the time of widespread demy- 
elination (5.38%  at 4 wpi; 8 wk of age). 
We next examined the proliferative capacity of the cul- 
tured cells during an in vitro pulse of [3H]thymidine (Table 
I). In this case proliferation in vitro was measured by adding 
[SH]thymidine  to the culture medium at 2  div,  fixing the 
cells 20 h later, and then identifying [3H]thymidine-labeled 
cells by autoradiography combined with three-fluorochrome 
immunocytochemistry,  as outlined in Fig. 1 B. The percent- 
age of O-2A lineage cells that were labeled in vitro with 
pH]thymidine was  approximately  ninefold higher in  cul- 
tures derived from diseased mice at 1 wpi than in cultures 
from age-matched control mice,  and was increased more 
than threefold at 4 wpi (Table I). Oligodendrocytes (Fig. 10), 
type 2 astrocytes (Fig. 11), O-2A progenitors (Fig. 12), and 
mixed phenotype cells were labeled with [3H]thymidine af- 
ter the 20-h terminal pulse. Remarkably, O-2A progenitors 
were the only cell type for which the increased percentage 
of [3H]thymidine-labeled  cells from demyelinated tissue was 
highly significant (4 wpi; demyelinated =  38.3 %, control = 
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astrocyte  phenotype  isolated  from demyelinated 
tissue (4 wpi) which was grown in culture for 3 d, 
fixed, and processed  for three-color  immunoflu- 
orescence.  (A) The cell surface membrane is im- 
munostained with an mAb against GC, visualized 
with  fluorescein.  (B) Intracellular  filaments are 
immunostained  with a polyclonal antiserum  rec- 
ognizing GFAP, visualized  with coumarin.  This 
cell was also labeled by 04, visualized with rhoda- 
mine (not shown). Bar, 50 ttm. 
0%; p  =  0.027,  as determined by paired two-tailed t test). 
Approximately 12-14%  of each of the other O-2A lineage 
cell types (oligodendrocytes, type 2  astrocytes, and mixed 
phenotype cells) were pH]thymidine-labeled in cultures de- 
rived from demyelinated tissue. Although the percentage of 
[3H]thymidine-labeled cells within each of these phenotypes 
alone was not increased significantly, when combined as a 
single group these three phenotypes accounted for a signifi- 
cant proliferative response in cultures of demyelinated tissue 
(4 wpi; demyelinated =  13.5 %, control =  4.3 %; p  =  0.029, 
as determined by paired two-tailed t test). Thus the in vivo 
proliferative response of O-2A lineage cells isolated from 
demyelinating tissues was retained in vitro. 
Since PDGF, IGF-I, and bFGF can each induce prolifera- 
tion of neonatal O-2A progenitor cells in the developing rat 
CNS (reviewed in Dubois-Dalcq and Armstrong, 1990), we 
assayed the mitogenic effect of these growth factors in our 
cultures of adult mouse spinal cord (see protocol outlined in 
Fig.  1 C).  We tested each growth factor at  1,  3, 4,  5,  and 
8 wpi since the effect of a particular growth factor may vary 
during the course of the disease. In cultures of demyelinating 
and remyelinating tissue, none of these three growth factors 
caused a significant increase in the percentage of O-2A lin- 
eage cells which  incorporate  pH]thymidine during a  20-h 
terminal pulse (p  =  0.691  for the difference between treat- 
ments,  as determined by ANOVA).  Similarly, preliminary 
data  from  control  cultures  indicated  that  treatment  with 
PDGF, IGF-I, or bFGF did not enhance the proliferation of 
O-2A lineage cells from normal adult mice. Thus, exogenous 
growth factors influenced phenotype expression (Fig. 9) but 
did not enhance the proliferation of O-2A lineage cells in our 
cultures. 
Discussion 
In  the  present  in  vitro  study,  we  have  characterized  the 
growth  and  differentiation  of glial cells isolated  from the 
CNS of mice during the course of demyelination and remy- 
(/  U)  3- 
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o 
o 
i_  o  9 
•  =  media 
'  ~  =  +PDGF 
"  /  X  "  +bFGF 
GF-I 
weeks  post  infection 
Figure 9. The relative abundance of type 2 astro- 
cytes and oligodendrocytes in spinal cord cultures 
from virus-inoculated  animals.  The  number of 
type 2 astrocytes and oligodendrocytes was deter- 
mined  as described  in Fig.  5.  In defined media 
alone, the proportion of  type 2 astrocytes increases 
during demyelination (3-5 wpi). Addition of bFGF 
(10 ng/nd) to the defined media between  1 and 3 
div exaggerates this shift toward the type 2 astro- 
cyte phenotype by decreasing the relative number 
of cells expressing GC. Treatment with IGF-I (100 
ng/ml) induces a larger proportion  of cells to ex- 
press the oligodendrocyte phenotype.  Exogenous 
PDGF (10 ng/ml) did not alter the ratio of type 2 
astxo~tes to oligodendrocytes. To minimize vari- 
ability between experiments, the cultures were prepared in parallel for each timepoint and as one completely matched set from mice inocu- 
lated at the same time with the demyelinating virus.  Each value represents the ratio from cell counts in an entire 35-mm dish.  A total 
of 1,793 cells were counted in the set of cultures.  To estimate the variability that might be expected between nonmatched experiments, 
the ratio of type 2 astrocytes to oligodendrocytes was compared in three similar experiments of cultures grown without exogenous growth 
factors. The asterisks denote values which fall outside of a 95 % confidence interval of the expected variability between experiments for 
cultures grown without exogenous growth factors. 
The Journal of Cell Biology, Volume 111, 1990  1190 Table £ Percentage of O-2A Lineage Cells Labeled with [JH]Thymidine 
I wpi  4  wpi 
Protocol  Control  MHV-A59  Control  MHV-A59 
2-h in vivo pulse 
(cells fixed at  1 div)  0.52  5:0.52 
20-h in vitro pulse 
(cells fixed at 3  div)  4.85  5:1,00 
4.96  +  2.18"  0 ±  0  5.38  +  2.51~ 
43.81  +  9.83§  4.68  +  2.7  17.48  5: 2.48¶ 
*p =  0.228;  ~tp  ffi 0.278;  Ig  --- 0,048;  qlp =  0.011. 
The percentage of dividing O-2A lineage cells in cultures from control and demyelinating  tissue (i and 4 wpi) was determined following  either a 2-h in vivo or 
20-h in vitro pulse of 3H-thymidine (see protocols outlined in Fig.  1, A and B). Each value is the percentage (+SEM) of total O-2A lineage cells (oligodendro- 
cytes, type 2 astrocytes, O-2A progenitors, and mixed phenotype cells combined) which were [~Hlthymidine-labeled  (greater than 10 autoradiographic  silver 
grains localized over each nucleus)  and represents the average of 2-3 dishes. Significance values were determined using the two-tailed  paired t test. A total of 
2,221 O-2A lineage cells were counted in this set of  6 experiments of  control mice (660 cells) matched with 6 experiments of MHV-A59 infected mice (1,561 cells). 
elination. Several differences were observed between the glial 
cell populations isolated from control and demyelinated spi- 
nal cords. First, the number of O-2A lineage cells (oligoden- 
drocytes, O-2A progenitors, type 2  astrocytes, and mixed 
phenotype cells combined) increased dramatically as demy- 
elination progressed and returned to near control levels as 
remyelination proceeded. Moreover, O-2A lineage cells de- 
rived from demyelinated  tissue differed from those of  control 
tissue by the presence of mixed oligodendrocyte-astrocyte 
phenotype cells and by their differentiation potential in re- 
sponse to exogenous  growth factors. Finally, both in vivo and 
in  vitro  [3H]thymidine  labeling  demonstrated  enhanced 
proliferation of O-2A lineage cells derived from demyeli- 
nated tissue, which correlates well with the increased num- 
ber of O-2A lineage cells observed in culture. The pheno- 
typic  plasticity  and  mitotic potential  O-2A  lineage  cells 
cultured from demyelinating/remyelinating tissue may re- 
fleet molecular and cellular events critical for efficient remy- 
elination in vivo. 
Studies of neonatal CNS tissue have shown that the growth 
and differentiation of O-2A lineage cells can be influenced 
in vitro by several  polypeptide growth factors, which are 
synthesized in the brain (for review, see Raft, 1989; Dubois- 
Dalcq and Armstrong, 1990).  PDGF stimulates the prolifer- 
ation of O-2A progenitor cells, which prevents premature 
differentiation  in vitro (Noble et al., 1988; Raff  et al., 1988). 
Figure 10, Thymidine-labeled  oligodandrocytes  are found in cultures from demyelinated  tissue. These cells were isolated from demyelinated 
tissue (4 wpi), fixed  at 3 die after a 20-h in vitro pulse of [3H]thymidine, and processed for autoradiography combined with three-color 
immunofluorescence. (.4 and D) The cell surface membranes are immunostained with antibody to GC, visualized with fluorescein (not 
shown: these cells also expressed 04 but not GFAP). (B and E) Phase contrast focusing in the plane of the autoradiographic emulsion. 
Arrows point to clusters of silver grains over each nucleus which indicate that these cells incorporated [3H]thymidine. (C and F) Phase 
contrast focusing in the plane of the cell processes., Bar, 50 #m. 
Armstrong et al.  In  Vitro Studies of  Neuroglia during Demyelination  1191 Figure 11. A type 2 astroeyte cultured from demyelinated tissue (4 wpi) and processed as described in Fig. 10 is identified by the presence 
of surface staining with 04 (A; rhodamine optics), intracellular expression of GFAP (B; coumarin optics) and the absence of labeling with 
GC antibody (C; fluoreseein optics). The cluster of silver grains over the nucleus (D, arrow) indicates that this cell incorporated [3H]thy- 
midine during the 20-h in vitro pulse.  (E) Phase contrast showing the cell processes. Bar, 50 #m. 
FGF is also mitogenic for O-2A lineage cells (Eccleston and 
Silberberg,  1985; Noble et al.,  1988; Besnard et al.,  1989). 
Both FGF and epidermal growth factor inhibit expression of 
myelin components  (Sheng  et al.,  1989).  IGF-I promotes 
proliferation of O-2A lineage cells while also inducing pre- 
cursor cells to develop into oligodendrocytes (McMorris and 
Dubois-Daicq,  1988).  A  protein  closely related  to ciliary 
neurotrophic factor is present in developing optic nerve and 
induces transient  expression of GFAP in O-2A progenitor 
cells in vitro (Hughes et al.,  1988;  Lillien et al.,  1988). 
Whether the growth factors mentioned above have an effect 
on O-2A lineage cells derived from adult CNS tissue is not 
yet  clear.  Human  oligodendrocytes  isolated  from  normal 
adult brain do not proliferate in response to treatment with 
several  growth  factors,  including  PDGF,  FGF,  epidermal 
growth factor, and interleukin 2 (Yong et al.,  1988).  Simi- 
larly,  in the present study we found that PDGF, bFGF,  or 
IGF-I did not induce mitosis of O-2A lineage cells cultured 
from adult  mice,  as  assayed by  [3H]thymidine  incorpora- 
tion.  However,  a  factor  secreted by  B104  neuroblastoma 
cells is mitogenic  for O-2A progenitors  and oligodendro- 
cytes cultured  from adult rat brain  (Hunter  et al.,  1988). 
Thus,  normal adult O-2A lineage cells are capable of pro- 
liferating when exposed to an adequate stimulus. Such a stim- 
ulus could be a factor (or factors) released in the CNS during 
demyelination since O-2A lineage cells in the spinal cord of 
MHV-A59 infected mice showed increased proliferation both 
in vivo (Godfraind  et al.,  1989) and in vitro  (the present 
data).  Interestingly,  some growth factors can influence the 
antigenic  phenotypes  of  O-2A lineage  cells  in  our cultures 
of  demyelinating/remyelinating  CNS. Basic  FGF decreased 
the percentage of O-2A lineage cells expressing GC, whereas 
IGF-I increased the proportion of oligodendrocytes relative 
to type 2 astrocytes. Thus bFGF and IGF-I might modulate 
phenotype expression  in  CNS development and  remyelin- 
ation. 
Proliferation of mature and immature oligodendrocytes in 
vivo has been described in several electron microscopic and 
autoradiographic  studies of experimental  demyelination in 
adult CNS (Herndon et al.,  1977;  Ludwin,  1979; Aranella 
and Herndon,  1984; Raine et al.,  1988). In our in vivo stud- 
ies  of remyelination  following coronavirus-induced  demy- 
elination in mice, we have used in situ hybridization and im- 
munolabeling techniques to analyze the expression of myelin 
genes and the presence of cell-type-specific antigens in oligo- 
dendrocytes and their precursors (Jordan et al.,  1989; God- 
fraind et al., 1989). We found that myelin basic protein mRNA 
isoforms containing  exon-2,  which are normally  abundant 
only during development, are reexpressed at dramatically in- 
creased levels during  remyelination  (Jordan  et al.,  1990). 
This recapitulation of molecular events characteristic of de- 
velopment suggests that newly generated oligodendrocytes 
are  responsible  for  remyelination  in  this  disease.  Studies 
using triple-label immunocytochemistry combined with au- 
toradiography have identified O-2A progenitor cells in 1 ~m 
frozen sections of the spinal cord of these infected mice (God- 
fraind et al., 1989). O-2A progenitors and O4-positive astro- 
cytes proliferated early in the course of the disease and some 
The Journal of Cell Biology, Volume 111,  1990  1192 Figure 12. An O-2A adult progenitor cultured from demyelinated tissue (4 wpi) and processed as described in Fig. 10 is recognized by 
its reactivity with the 04 antibody (A; rhodamine optics) and in the absence of staining with GC (B; fluorescein optics) or GFAP (C; 
coumarin optics) antibodies. The cluster of silver grains over the nucleus (D, arrow) indicates that this cell incorporated [3H]thymidine 
during the 20-h in vitro pulse. (E) Phase contrast showing the cell processes. Note that numerous microglial cells are also present in this 
culture. Bar, 50 #m. 
cells generated during the demyelination stage later devel- 
oped into oligodendrocytes (Godfraind et al.,  1989). 
In the present study, we demonstrate that the mitotic activ- 
ity of O-2A lineage cells observed in vivo during demyelina- 
tion has been maintained in vitro. This proliferation might 
be mediated by factors active in the culture milieu or by sig- 
nals experienced in vivo which persist in vitro. The nature 
of the signal(s) triggering this proliferation is presently un- 
known. Reactive astrocytes may secrete mitogenic factors 
while microglia can synthesize lymphokines in response to 
trauma (Giulian, 1987; Giulian et al.,  1988).  Since micro- 
glial cells are present in our cultures of adult spinal cord and 
are much more prevalent in cultures of demyelinated tissue, 
it is possible that O-2A lineage cells proliferate due to factors 
released into the culture milieu by these cells. In addition to 
soluble factors, denuded axons or axolemmal components, 
which are mitogenic for oligodendrocytes from developing 
CNS  (Chen and DeVries,  1989),  may act as mitogens for 
O-2A lineage cells during demyelination. Denuded axons in 
demyelinated lesions may stimulate proliferation directly, or 
may "prime" O-2A  lineage cells to divide in response to 
specific growth factors. Previous studies have shown that oli- 
godendrocytes isolated from adult spinal cord and express- 
ing GC, but not myelin basic protein, can divide in the pres- 
ence of neurons (Wood and Bunge, 1986).  Along with O-2A 
progenitors, oligodendrocytes expressing GC also prolifer- 
ated in our cultures from remyelinating animals. Thus, pro- 
liferating oligodendrocytes could also be a major source of 
remyelinating cells. Type 2 astrocytes and cells with a mixed 
oligodendrocyte-astrocyte  phenotype also proliferated in re- 
sponse to demyelination. Cells with characteristics of both 
oli~  and astrocyte phenotypes have been described 
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al., 1961; Carrollet al., 1987; Godfralnd et al., 1989; Paine, 
1989).  Additionally,  ciliary neurotrophic  factor,  which in- 
duces transient GFAP expression in neonatal O-2A progeni- 
tors in vitro,  is much more abundant  in regenerating  CNS 
tissue (Nieto-Sampedro et al., 1983) and might possibly in- 
duce a mixed phenotype in vivo. The presence of phenotypic 
characteristics  of  both oligodendrocytes and astrocytes in the 
same cell indicates that some degree of plasticity is possible 
between these two differentiation pathways. Mixed phenotype 
cells might be precursor cells at an intermediate  bipotential 
stage which are responding  to two differentiation  signals 
simultaneously,  or may be mature cells in a state of trans- 
differentiation between astrocyte and oligodendrocyte pheno- 
types.  By either mechanism, mixed phenotype cells might 
provide additional ways to increase the number of oligoden- 
drocytes available for remyelination. 
Now that we have established and characterized  an in vitro 
system of glial  cells derived from normal and demyelinat- 
ing/remyelinating  adult CNS, we can design future experi- 
ments to determine which of the proliferating  cells provide 
new oligodendrocytes  in remyelination and which factors en- 
hance this pathway. Since we have recently developed a simi- 
lar  in  vitro system  from adult human  CNS  (Dorn et al., 
1990),  such experiments  could also be performed with hu- 
man oligodendrocyte lineage cells. The study of the growth 
and differentiation properties of the glial cell types involved 
in remyelination  may lead to the elaboration of strategies to 
promote remyelination  in human  demyelinating  diseases. 
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